Cancer–neuronal crosstalk and the startups working to silence it

Cancer–neuronal crosstalk and the startups working to silence it

Investors back ‘cancer neuroscience’ outfits as the field breaks out from academia.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nature biotechnology 2020-02, Vol.38 (2), p.115-117
1. Verfasser: Dolgin, Elie
Format: Artikel
Sprache:eng
Schlagworte:
Agriculture
Animals
Antineoplastic Agents - pharmacology
Antineoplastic Agents - therapeutic use
Bioinformatics
Biomedical and Life Sciences
Biomedical Engineering/Biotechnology
Biomedicine
Biotechnology
Cancer
Crosstalk
Development and progression
Drug Industry
Entrepreneurship
Humans
Life Sciences
Mice
Neoplasms - drug therapy
Neoplasms - pathology
Nervous system
Neurons
Neurons - pathology
Neurosciences
New business enterprises
News
Planning
Signal Transduction - drug effects
Venture capital companies
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Investors back ‘cancer neuroscience’ outfits as the field breaks out from academia.
ISSN:1087-0156
1546-1696
DOI:10.1038/s41587-020-0411-9